Proactive strategies, including communication and collaboration, are vital for improving medication adherence in chronic illness. Personalized interventions are crucial for positive health outcomes, ...

Sentiment soured in May when Sanofi reported the failure of a phase 3 trial of its Regeneron-partnered IL-33 drug candidate ...

Please provide your email address to receive an email when new articles are posted on . CLS-AX achieved stable best corrected visual acuity and central subfield retinal thickness at 36 weeks. The ...

Merck's Coralreef Lipids trial showed enlicitide cut LDL-C and other lipid markers, while pooled Verquvo data hinted at heart ...

Primary biliary cholangitis is a rare, chronic cholestatic liver disease characterized by the destruction of interlobular bile ducts, leading to cholestasis and liver fibrosis. Whether elafibranor, an ...

DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two ...

“Our results indicate that the primary treatment modality should not be used to exclude patients from secondary surgery,” said MSK gynecologic oncology fellow Beryl Manning-Geist, MD, co-lead author ...

Kerala sees improvement in student retention but struggles with rising dropout rates, especially at primary and secondary levels.